01:36 , Jan 20, 2017 |  BC Extra  |  Clinical News

Stanford team reports live imaging of CAR T cells

In a paper published online by Science Translational Medicine on Wednesday, researchers reported the first PET-based imaging of chimeric antigen receptor T cells in a cohort of seven glioma patients in a clinical trial. Stanford...
07:00 , Oct 4, 2010 |  BC Week In Review  |  Company News

CellCyte management update

CellCyte Genetics Corp. (OTCBB:CCYG), Bellevue, Wash.   Business: Gene/Cell therapy   Transitioned: Douglas Pat Cerretti to president in July, while remaining CSO and director of business development  ...
08:00 , Nov 16, 2009 |  BC Week In Review  |  Company News

CellCyte management update

CellCyte Genetics Corp. (OTCBB:CCYG), Bellevue, Wash.   Business: Gene/Cell therapy   Hired: Douglas Cerretti as CSO and director of business development, formerly scientific director at Amgen Inc.; he replaces Ron Berninger, who resigned  ...
07:00 , Sep 14, 2009 |  BC Week In Review  |  Company News

CellCyte gene/cell therapy news

The SEC filed two suits in the U.S. District Court for the Western District of Washington against CellCyte and two former executives, alleging the parties made misleading statements about the status of an investigational stem...
07:00 , May 25, 2009 |  BioCentury  |  Finance

Stem cell stocks

Stem cell stocks Company 5/22 cls 5/22 % chg Week % chg MicroIslet Inc. (OTCBB:MIIS) $0.01 67% 67% ReNeuron plc (LSE:RENE) 5.5p 10% 22% Mesoblast Ltd. (ASX:MSB) A$0.79 5% 2% Intercytex Group plc (LSE:ICX) 10.75p...
07:00 , Jul 14, 2008 |  BC Week In Review  |  Company News

CellCyte gene/cell therapy news

CellCyte retained InCap Group Inc. to explore strategic alternatives including partnerships for the company’s cell expander bioreactor and stem cell delivery technologies. The company’s lead compound, CCG-TH30, is in preclinical development to treat myocardial infarction....
07:00 , May 26, 2008 |  BC Week In Review  |  Company News

CellCyte scientific advisory board update

CellCyte Genetics Corp. (OTCBB:CCYG), Bothell, Wash.   Business: Gene/Cell therapy   Appointed: Jay Traverse, associate professor of medicine at the University of Minnesota  ...
07:00 , Jun 4, 2007 |  BC Week In Review  |  Company News

CellCyte management update

CellCyte Genetics Corp. (CCYG), Kirkland, Wash.   Business: Gene/Cell therapy   Hired: Mark Reys as VP of operations  ...
07:00 , May 21, 2007 |  BC Week In Review  |  Company News

CellCyte gene/cell therapy news

CCYG will move its headquarters to Bothell, Wash., in September. CellCyte Genetics Corp. (CCYG), Kirkland, Wash.   Business: Gene/Cell therapy  ...
07:00 , May 14, 2007 |  BC Week In Review  |  Company News

CellCyte, Sigma-Aldrich deal

SIAL's SAFC Pharma manufacturing unit will supply CCYG with preclinical batches of CCYG's lead compound, CCG-TH30. The glycoprotein that helps stem cells target the heart is expected to begin Phase I testing to treat congestive...